Midi and Evernow describe virtual menopause care, and both now publish insurance-billed video options. Evernow also describes a membership route, so comparing these brands as simply insured care versus a cash subscription would leave out a current choice.
We checked their official HRT pages on September 21, 2026 without booking appointments. The figures below describe public services, not personal quotes. CoreAge's featured banner is promotional and does not establish an available menopause HRT alternative.
In this entry
Select the route before the number
Midi describes an initial assessment and continued-care visits. Evernow describes choosing a virtual visit or membership, with provider contact and pharmacy options following the selected arrangement. Ask which format you are actually enrolling in.
The Midi review and Evernow review provide the individual background. If your expected follow-up uses a different format from the first visit, include that difference in the decision rather than pricing only the entry point.
Verify coverage at the appointment level
Midi's page describes commercial coverage with state and plan checks, plus explicit Medicaid/Medi-Cal restrictions and Medicare self-pay conditions. Evernow lists several major commercial plans for video care. Neither statement confirms coverage of every appointment by every insurer using the same name.
Use the insurance shortlist to prepare questions about the clinician, location, deductible and pharmacy. Ask for your own estimate; the existence of an insurance pathway does not remove cost-sharing or establish that all medicines are covered.
Keep self-pay units consistent
Midi's public self-pay figures are $250 for the first visit and $150 for continued visits. Evernow lists uninsured video visits at $150 and membership beginning at $35 per month, with medication separate. An appointment and a month of access are not identical units of care.
Ask whether video visits generate an additional fee within the Evernow plan you are offered. Do not automatically combine every listed number, and do not assume the smallest number includes everything. The care-plan guide helps define a realistic period for comparison.
Identify the finished prescription
Midi's HRT page emphasizes approved bioidentical treatments. Evernow's current FAQ includes compounded formulations among its options. Obtain the exact proposed medicine before deciding its approval category; neither provider's name substitutes for product information.
The compounding explainer separates regulatory status from ingredient terminology. Ask for evidence relevant to the intended use, rather than treating broad claims about midlife wellbeing as proof of disease prevention or benefit for every symptom.
Include the pharmacy handoff
Evernow describes local-pharmacy supply or delivery. For either service, establish where the prescription will be filled, how benefits are processed and who handles availability problems. Add the actual supply and expected reviews to the worksheet.
If changing services, bring the records in the transfer guide and confirm responsibility before an existing refill runs out. A new portal account does not prove that the prescription has been accepted for continuation.
The more useful choice depends on the available clinician, selected care route and complete expense. Public service information can clarify those differences; it cannot establish a head-to-head clinical winner or predict an individual's response to treatment.
CHECK THE ORIGINAL
The source record
Provider pages document their own offers. Medical and regulatory sources provide treatment context. This is not a record of personal patient testing. Latest source check: September 21, 2026.